PEMbo: From genotype to phenotype: patho-evolution of Mycobacterium bovis French strains
Bovine tuberculosis (bTB), mainly caused by Mycobacterium bovis, is an ancient worldwide zoonotic disease intimately and historically associated to cattle rearing. Although developing countries are most suffering from bTB, this disease remains a major problem in some industrialised countries. When cattle breeding developed as a real industry, strong control strategies were set up first in Europe and then in other developed countries. In France, the introduction of a compulsory national wide control campaign in the sixties led to a relatively rapid decline in the number of infected herds, turning from an annual herd prevalence of about 25% to less than 0.1% in 50 years. These costly measures greatly reduced bTB incidence and offered sanitary guarantees: France obtained the officially bTB free status from the European Union in 2000. However, bTB has not been completely eradicated. Despite considerable financial and social efforts to tackle once for all the disease, bTB seems to be slowly but continuously rising and persisting, mainly at regional levels. This indicates that either control measures are not effective or that there exist overlooked risk factors. Indeed, investigations in these endemic areas revealed that wild boar, badgers and deer were regularly found infected with M. bovis and thus the emergence of the disease at a domestic and wildlife interface.
It is within this framework that the thesis project of A. Hauer, took place. Her work focused on the genotyping of M. bovis strains available at the National Tuberculosis Reference Laboratory (ANSES) in order to obtain the data allowing to study the dynamics of this zoonotic disease and to better understand its complex nature. The genotypes of the complete collection of strains isolated from livestock and wild animals in France between 1978 and 2011 were obtained by conventional genotyping methods: spoligotyping and MLVA. Strains of predominant spoligotype groups SB0120, SB0134, SB0121 and the “F4 family”, were differentiated more finely by MLVA typing which increases the diversity power for molecular epidemiology studies. Approximately 600 genetic profiles were defined from more than 2,000 strains. A decrease in the genetic variability over time and changes in the geographical distribution of strains were observed. They could be explained by changes in breeding practices and by the proliferation of certain dominant genotypes in multi-host systems (domestic-wild animals) in high prevalence regions. In order to deepen our knowledge in the epidemiology of bTB, the complete sequencing of 87 M. bovis strains representative of the genetic diversity in France was carried out. Comparison of these sequencing data with the M. bovis AF2122 reference sequence identified single nucleotide polymorphism (SNP) mutations and allowed to construct a finer phylogeny of these strains. Four of these genomes have been published in international databases. The clonal groups previously described in France by conventional genotyping were confirmed by analysis of SNPs and other less dominant groups were also identified for the first time. This work highlighted the emergence of dominant genotypes and the preponderant role of wildlife and the environment in maintaining infectious foci of bTB.
Subsequent to these studies, which focused on the genotypic diversity of M. bovis strains, and in order to answer the hypothesis of the emergence of certain successful strains circulating in multi-host systems, we propose to study the biology of these strains by genomic and biochemical-phenotypic approaches.
The aim of this thesis project, a collaborative study between ANSES, Animal Health Laboratory (Maisons-Alfort) and INRA, Infectiology and Public Health laboratory (Nouzilly), two French EJP Partners, is to better understand the complex biology of M. bovis through the study of the complete genomes of a large panel of isolates of interest. This project will be structured around three parts:
- Obtaining reference sequences by Illumina / PacBio sequencing of strains belonging to main clonal groups.
- Identification of genomic events (insertion / deletion or broad sequence polymorphism (LSP)) by comparison study of genetic variation: analysis focused on the study of 182 virulence genes, genes involved in envelope biosynthesis and the study of excreted antigens.
- Study of the antigenic variation: biochemical and lipidomic analyses of the strains.
About me: I consider myself as a hard-worker. During my undergraduate degree, I worked as an intern on topics dealing from cell biology to molecular biology. I have already worked in the mycobacterial field in my last internship (Poitiers University), in particular with Mycobacterium chelonae, for which I developed an amoeba infection model. The goal was to study how bacterial diversity evolves in a drinking water treatment plant. Populations of microorganisms were studied by high throughput sequencing (MiSeq Illumina). The presence of emerging pathogens such as mycobacteria was confirmed by culture and identified by MALDI TOF analysis. As a secondary activity, I am also the president of “Therapeutic IMPACT” association, which goal is to support and promote research projects against cancer.
What motivated me to do a PhD: After my thesis, I would like to continue to work as a researcher in biology, especially in the molecular biology and microbiology fields. I’ve found the OHEJP PEMbo thesis’ project of special interest because the topic is in relationship with mycobacteria and genome sequencing but I am also very motivated to start working in this subject because of the important social and economic impact bovine tuberculosis. Besides, this thesis will allow me to continue to pursue my education in microbiology, on working in a biohazard level 3 laboratory, to consolidate my knowledge in bioinformatics, and to prepare my future life as a complete scientist.